08 December 2022: Human Study
Use of Estimated Glomerular Filtration Rate and Urine Albumin-Creatinine Ratio Based on KDIGO 2012 Guideline in a Thai Community Hospital: Prevalence of Chronic Kidney Disease and its Risk Factors
Veeravan Lekskulchai ACDEF*DOI: 10.12659/MSMBR.938176
Med Sci Monit Basic Res 2022; 28:e938176
Table 2 Demographics of the study patients.
| Male | Female | Total | |
|---|---|---|---|
| 26041 (41.48%) | 36739 (58.52%) | 62780 | |
| Age; range (mean±SD) | 18–102 (51.40±18.36) | 18–107 (47.93±18.73) | 18–107 (49.37±18.65) |
| 15883 (43.91%) | 20289 (56.09%) | 36172 | |
| Age; range (mean±SD) | 18–101 (55.88±16.66) | 18–106 (54.92±16.78) | 18–106 (55.34±16.73) |
| Diabetes; n (%) | 1761 (41.35%) | 2498 (58.65%) | 4259 |
| Non-diabetes hypertension: n (%) | 2046 (42.39%) | 2781 (57.61%) | 4827 |
| Non-diabetes non-hypertensive dyslipidemia: n (%) | 448 (35.11%) | 828 (64.89%) | 1276 |
| Non-diabetes non-hypertensive CVD: n (%) | 1793 (56.56%) | 1377 (43.44%) | 3170 |
| Others: n (%) | 9835 (43.44%) | 12805 (56.56%) | 22640 |
| 1392 (41.93%) | 1928 (58.07%) | 3320 | |
| Age; range (mean±SD) | 18–93 (61.54±12.02) | 19–95 (61.32±12.44) | 18–95 (61.41±12.27) |
| Diabetes; n (%) | 1083 (41.85%) | 1505 (58.15%) | 2588 |
| Non-diabetes hypertension: n (%) | 189 (40.21%) | 281 (59.79%) | 470 |
| Non-diabetes non-hypertensive dyslipidemia: n (%) | 38 (38.00%) | 62 (62.00%) | 100 |
| Non-diabetes non-hypertensive CVD: n (%) | 13 (52.00%) | 12 (48.00%) | 25 |
| Others: n (%) | 69 (50.36%) | 68 (49.64%) | 137 |
| 1115 (40.81%) | 1617 (59.19%) | 2732 | |
| Age; range (mean±SD) | 18–91 (61.13±11.82) | 19–91 (60.87±12.25) | 18–91 (60.98±12.08) |
| Diabetes with HbA1C ≤6.5%; n (%) | 374 (43.29%) | 490 (56.71%) | 864 |
| Diabetes with HbA1C >6.5%; n (%) | 613 (37.91%) | 1004 (62.09%) | 1617 |
| Non-diabetes with HbA1C ≤6.5%; n (%) | 128 (51.00%) | 123 (49.00%) | 251 |
| SCr – serum creatinine; CVD – cardiovascular disease; UACR – urine albumin-creatinine ratio; HbAC – hemoglobin AC. | |||